SCHEMBL8213451

SCHEMBL8213451

CCCCOC(=O)C1OCOC1C(=O)OCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
TSHR P16473 3/20 0.46
HPGD P15428 1/20 0.46
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
POLB P06746 1/20 0.41
HCAR2 Q8TDS4 1/20 0.39
NAAA Q02083 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
PPM1B O75688 1/20 0.37
PTPN1 P18031 1/20 0.37
PPP1CC P36873 1/20 0.37
EPHX1 P07099 1/20 0.36
MAPK1 P28482 2/20 0.36
ESR1 P03372 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21076400 0.85 ATM (0.43) ALDH1A1TSHRHPGDATMSMN1; SMN2
SCHEMBL85862 0.79 TSHR (0.46) ALDH1A1TSHRHPGDLMNAPPM1B
SCHEMBL7209322 0.79 TSHR (0.46) ALDH1A1TSHRHPGDLMNAPPM1B
SCHEMBL7203762 0.79 TSHR (0.46) ALDH1A1TSHRHPGDLMNAPPM1B
SCHEMBL9566677 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHPGDATMSMN1; SMN2
SCHEMBL338399 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHPGDATMSMN1; SMN2
SCHEMBL9566680 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHPGDATMSMN1; SMN2
SCHEMBL9566682 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHPGDATMSMN1; SMN2
SCHEMBL3043061 0.78 ALDH1A1 (0.48) ALDH1A1TSHRHPGDATMSMN1; SMN2
SCHEMBL8207602 0.78 ALDH1A1 (0.40) ALDH1A1TSHRHPGDATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11695158-B2 Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same MU IONIC SOLUTIONS CORPORATION (JP) 2023-07-04 US disclosed
US-11695158-B2 Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same MU IONIC SOLUTIONS CORPORATION (JP) 2023-07-04 US disclosed
US-20210320334-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME MU IONIC SOLUTIONS CORPORATION (JP) 2021-10-14 US disclosed
US-20190198928-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME UBE INDUSTRIES, LTD. (JP) 2019-06-27 US disclosed
US-10263285-B2 Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same UBE INDUSTRIES, LTD. (JP) 2019-04-16 US disclosed
US-20180166746-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME UBE INDUSTRIES, LTD. (JP) 2018-06-14 US disclosed
US-20180166746-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME UBE INDUSTRIES, LTD. (JP) 2018-06-14 US disclosed
EP-0988299-A1 POLYMERISABLE, OPTICALLY ACTIVE DIOXOLANE DIESTERS Rolic AG (CH) 2000-03-29 EP disclosed
WO-1998055473-A1 POLYMERISABLE, OPTICALLY ACTIVE DIOXOLANE DIESTERS ROLIC AG (CH) 1998-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166746-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME SLC9A2, VDAC1, SCO2 ALDH1A1 1748/4885TSHR 2418/4885HPGD 3069/4885
US-20190198928-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME SLC9A2, VDAC1, SCO2 ALDH1A1 1748/4885TSHR 2418/4885HPGD 3069/4885
US-11695158-B2 Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same SLC9A2, VDAC1, SCO2 ALDH1A1 1748/4885TSHR 2418/4885HPGD 3069/4885
US-10263285-B2 Nonaqueous electrolyte, capacitor device using same, and carboxylic acid ester compound used in same SLC9A2, VDAC1, SCO2 ALDH1A1 1748/4885TSHR 2418/4885HPGD 3069/4885
US-20210320334-A1 NONAQUEOUS ELECTROLYTE, CAPACITOR DEVICE USING SAME, AND CARBOXYLIC ACID ESTER COMPOUND USED IN SAME SLC9A2, VDAC1, SCO2 ALDH1A1 1748/4885TSHR 2418/4885HPGD 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.